Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women?
- PMID: 25393995
- PMCID: PMC4224861
- DOI: 10.7448/IAS.17.4.19486
Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women?
Abstract
Introduction: High rates of hepatotoxicity have been observed among HIV-positive pregnant women using antiretroviral therapy (ART). However, the extent to which pregnancy affects the risk of ART-induced hepatotoxicity is unclear since studies in this area have generated conflicting results.
Material and methods: Combined data from the UK Collaborative HIV Cohort (UK CHIC) study and the UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC) were used. Alanine aminotransferase (ALT) data were assessed according to the Division of AIDS toxicity guidelines to identify factors associated with liver enzyme elevation (LEE) (grade 1-4). Women starting ART in 2000-11 aged 16-49 years were included irrespective of pregnancy status at ART start. Cox proportional hazards were used to assess the associations between fixed (ethnicity, exposure group, HBV/HCV co-infection, prior ART use, and age, year, pregnancy status, viral load and CD4 count at ART start) and time-dependent covariates (pregnancy status, age, year, CD4 count, viral load, duration on ART) and the risk of LEE.
Results: Of the 3426 women included, one-quarter (25.0%, n=857) were pregnant during follow-up and 14.4% (n=492) started ART during pregnancy. The rate of LEE was 15/100 person-years (PY) during pregnancy and 6.1/100 PY outside pregnancy. The risk of LEE was increased during pregnancy (adjusted hazard ratio (aHR) 1.61 [1.26-2.06], p<0.001), including in secondary analysis excluding 493 women pregnant when starting ART. Other factors independently associated with LEE were lower CD4 count (<250 cells/mm(3) vs. 251-350 cells/mm(3) aHR 1.25 [1.02-1.54], p=0.03), HBV/HCV co-infection (aHR 1.94 [1.58-2.39], p<0.001), HIV acquired via injecting drug use (aHR 1.61 [1.15-2.24], p=0.01 vs. heterosexually) and calendar year (aHR 1.05 [1.02-1.08], p<0.001 per one year increase). Three ART drugs were associated with increased risk of LEE (efavirenz aHR 1.27 [1.06-1.50], p-value 0.008; maraviroc 4.19 [1.34-13.1], p=0.01; and nevirapine 1.59 [1.30-1.95], p-value <0.001). Use of zidovudine was associated with decreased risk of LEE (aHR 0.74 [0.63-0.87], p<0.001) as was increasing time on an NNRTI-based regimen (aHR 0.91 [0.86-0.96], p<0.001 per additional year).
Conclusions: Pregnant women were at increased risk of LEE, highlighting the importance of close monitoring of toxicity biomarkers during pregnancy.
Similar articles
-
Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal Cohort.J Acquir Immune Defic Syndr. 2019 May 1;81(1):83-94. doi: 10.1097/QAI.0000000000001963. J Acquir Immune Defic Syndr. 2019. PMID: 30702449
-
Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy.AIDS. 2015 Apr 24;29(7):801-9. doi: 10.1097/QAD.0000000000000620. AIDS. 2015. PMID: 25710412 Free PMC article.
-
[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Enferm Infecc Microbiol Clin. 2012. PMID: 22633764 Spanish.
-
Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals.AIDS. 2010 Jan 2;24(1):109-14. doi: 10.1097/QAD.0b013e3283323941. AIDS. 2010. PMID: 19926957 Free PMC article.
-
API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.J Assoc Physicians India. 2006 Jan;54:57-74. J Assoc Physicians India. 2006. PMID: 16649742 Review.
Cited by
-
Antiretroviral Therapy in Pregnancy: A 2023 Review of the Literature.Curr HIV/AIDS Rep. 2024 Feb;21(1):1-10. doi: 10.1007/s11904-024-00688-y. Epub 2024 Jan 26. Curr HIV/AIDS Rep. 2024. PMID: 38277098 Free PMC article. Review.
-
Liver damage in patients living with HIV on antiretroviral treatment with normal baseline liver function and without HBV/HCV infection: an 11-year retrospective cohort study in Guangxi, China.BMJ Open. 2019 Apr 2;9(4):e023140. doi: 10.1136/bmjopen-2018-023140. BMJ Open. 2019. PMID: 30944128 Free PMC article.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials